| 000 | 01787 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517122602.0 | ||
| 264 | 0 | _c20180403 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1559-0259 | ||
| 024 | 7 |
_a10.1007/s12012-016-9387-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMisner, D L | |
| 245 | 0 | 0 |
_aCardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines. _h[electronic resource] |
| 260 |
_bCardiovascular toxicology _c07 2017 |
||
| 300 |
_a307-318 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytokines _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEmbryonic Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtoxicity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 2-Ring _xtoxicity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aNicotinamide Phosphoribosyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 |
_aSulfones _xtoxicity |
| 700 | 1 | _aKauss, M A | |
| 700 | 1 | _aSingh, J | |
| 700 | 1 | _aUppal, H | |
| 700 | 1 | _aBruening-Wright, A | |
| 700 | 1 | _aLiederer, B M | |
| 700 | 1 | _aLin, T | |
| 700 | 1 | _aMcCray, B | |
| 700 | 1 | _aLa, N | |
| 700 | 1 | _aNguyen, T | |
| 700 | 1 | _aSampath, D | |
| 700 | 1 | _aDragovich, P S | |
| 700 | 1 | _aO'Brien, T | |
| 700 | 1 | _aZabka, T S | |
| 773 | 0 |
_tCardiovascular toxicology _gvol. 17 _gno. 3 _gp. 307-318 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12012-016-9387-6 _zAvailable from publisher's website |
| 999 |
_c26551385 _d26551385 |
||